Avanos Medical (AVNS) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Avanos Medical Revenue Highlights

Latest Revenue (Y)

$687.80M

Latest Revenue (Q)

$170.40M

Main Segment (Y)

Digestive Health

Main Geography (Y)

UNITED STATES

Avanos Medical Revenue by Period

Avanos Medical Revenue by Year

Date	Revenue	Change
2024-12-31	$687.80M	2.15%
2023-12-31	$673.30M	-17.89%
2022-12-31	$820.00M	10.13%
2021-12-31	$744.60M	4.17%
2020-12-31	$714.80M	2.47%
2019-12-31	$697.60M	6.94%
2018-12-31	$652.30M	6.65%
2017-12-31	$611.60M	-61.59%
2016-12-31	$1.59B	1.14%
2015-12-31	$1.57B	-5.84%
2014-12-31	$1.67B	-0.32%
2013-12-31	$1.68B	-0.39%
2012-12-31	$1.68B	1.45%
2011-12-31	$1.66B	-

Avanos Medical generated $687.80M in revenue during NA 2024, up 2.15% compared to the previous quarter, and up 98.60% compared to the same period a year ago.

Avanos Medical Revenue by Quarter

Date	Revenue	Change
2024-09-30	$170.40M	-0.76%
2024-06-30	$171.70M	3.37%
2024-03-31	$166.10M	-4.15%
2023-12-31	$173.30M	1.17%
2023-09-30	$171.30M	1.12%
2023-06-30	$169.40M	-11.63%
2023-03-31	$191.70M	-11.86%
2022-12-31	$217.50M	7.62%
2022-09-30	$202.10M	-0.44%
2022-06-30	$203.00M	2.84%
2022-03-31	$197.40M	2.07%
2021-12-31	$193.40M	5.05%
2021-09-30	$184.10M	-1.23%
2021-06-30	$186.40M	3.15%
2021-03-31	$180.70M	-2.32%
2020-12-31	$185.00M	-0.38%
2020-09-30	$185.70M	13.44%
2020-06-30	$163.70M	-9.26%
2020-03-31	$180.40M	-4.95%
2019-12-31	$189.80M	10.74%
2019-09-30	$171.40M	-0.46%
2019-06-30	$172.20M	4.87%
2019-03-31	$164.20M	-3.35%
2018-12-31	$169.90M	2.91%
2018-09-30	$165.10M	2.61%
2018-06-30	$160.90M	2.88%
2018-03-31	$156.40M	-126.75%
2017-12-31	$-584.60M	-245.64%
2017-09-30	$401.40M	0.55%
2017-06-30	$399.20M	0.91%
2017-03-31	$395.60M	-3.51%
2016-12-31	$410.00M	3.14%
2016-09-30	$397.50M	-0.63%
2016-06-30	$400.00M	3.95%
2016-03-31	$384.80M	-4.14%
2015-12-31	$401.40M	3.06%
2015-09-30	$389.50M	0.05%
2015-06-30	$389.30M	-1.24%
2015-03-31	$394.20M	-10.29%
2014-12-31	$439.40M	7.56%
2014-09-30	$408.50M	-1.21%
2014-06-30	$413.50M	0.68%
2014-03-31	$410.70M	-4.78%
2013-12-31	$431.30M	2.81%
2013-09-30	$419.50M	0.87%
2013-06-30	$415.90M	1.24%
2013-03-31	$410.80M	-

Avanos Medical generated $170.40M in revenue during Q3 2024, up -0.76% compared to the previous quarter, and up 100.59% compared to the same period a year ago.

Avanos Medical Revenue Breakdown

Avanos Medical Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Interventional Pain	$167.30M	$162.50M	-	-	-
Digestive Health	$396.40M	$371.60M	-	-	-
Respiratory health	-	-	$135.90M	$157.60M	-
Pain Management	-	-	$343.70M	$264.80M	$243.60M
Chronic Care	-	-	$476.30M	$479.80M	$471.20M
Interventional pain	-	-	$183.60M	$102.10M	-
Digestive health	-	-	$340.40M	$322.20M	-
Acute pain	-	-	$160.10M	$162.70M	-

Avanos Medical's latest annual revenue breakdown by segment (product or service), as of Dec 24: Digestive Health (70.32%), and Interventional Pain (29.68%).

Quarterly Revenue by Product

Product/Service	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
Digestive Health	$105.80M	$98.20M	$97.70M	$94.70M	$183.60M	$95.00M	$93.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Interventional pain	-	$41.90M	$41.70M	$40.20M	$42.20M	$41.60M	$35.80M	$47.40M	$47.50M	$49.50M	$39.30M	-	-	-	-	-	-	-	-	-
Chronic Care	-	-	-	-	-	-	-	$121.20M	$128.80M	$115.70M	$112.30M	$119.40M	$125.60M	$117.10M	$116.00M	$121.10M	$116.00M	$119.30M	$120.20M	$115.70M
Acute pain	-	-	-	-	-	-	-	$34.70M	$41.30M	$38.90M	$41.20M	$38.70M	-	-	-	-	-	-	-	-
Digestive health	-	-	-	-	-	-	-	$88.80M	$92.90M	$85.90M	$80.20M	$81.40M	-	-	-	-	-	-	-	-
Pain Management	-	-	-	-	-	-	-	$70.50M	$88.70M	$86.40M	$90.70M	$78.00M	$67.80M	$67.00M	$70.40M	$59.60M	$69.00M	$66.40M	$43.50M	$64.70M
Respiratory health	-	-	-	-	-	-	-	$32.40M	$35.90M	$29.80M	$32.10M	$38.00M	-	-	-	-	-	-	-	-

Avanos Medical's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Digestive Health (100.00%).

Avanos Medical Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
UNITED STATES	$529.10M	$467.00M	$560.70M	$521.60M	$482.00M

Avanos Medical's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (100.00%).

Avanos Medical Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ITGR	Integer	$1.72B	$746.27M
CNMD	CONMED	$1.31B	$316.70M
LIVN	LivaNova	$1.25B	$318.11M
AVNS	Avanos Medical	$687.80M	$170.40M
NVRO	Nevro	$408.52M	$104.16M
AORT	Artivion	$388.54M	$95.78M
GKOS	Glaukos	$383.48M	$96.67M
FNA	Paragon 28	$256.18M	$61.02M
TMCI	Treace Medical Concepts	$209.36M	$45.09M
KIDS	OrthoPediatrics	$204.73M	$52.80M
AXGN	AxoGen	$187.34M	$48.64M
ANIK	Anika Therapeutics	$166.66M	$38.75M
ESTA	Establishment Labs	$166.03M	$40.23M
SRDX	Surmodics	$126.08M	$29.92M
SGHT	Sight Sciences	$79.87M	$20.16M
OFIX	Orthofix Medical	-	$198.62M

AVNS Revenue FAQ

What is Avanos Medical’s yearly revenue?

Avanos Medical's yearly revenue for 2024 was $687.8M, representing an increase of 2.15% compared to 2023. The company's yearly revenue for 2023 was $673.3M, representing a decrease of -17.89% compared to 2022. AVNS's yearly revenue for 2022 was $820M, representing an increase of 10.13% compared to 2021.

What is Avanos Medical’s quarterly revenue?

Avanos Medical's quarterly revenue for Q3 2024 was $170.4M, a -0.76% decrease from the previous quarter (Q2 2024), and a -0.53% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $171.7M, a 3.37% increase from the previous quarter (Q1 2024), and a 1.36% increase year-over-year (Q2 2023). AVNS's quarterly revenue for Q1 2024 was $166.1M, a -4.15% decrease from the previous quarter (Q4 2023), and a -13.35% decrease year-over-year (Q1 2023).

What is Avanos Medical’s revenue growth rate?

Avanos Medical's revenue growth rate for the last 3 years (2022-2024) was -16.12%, and for the last 5 years (2020-2024) was -3.78%.

What are Avanos Medical’s revenue streams?

Avanos Medical's revenue streams in c 24 are Interventional Pain, and Digestive Health. Interventional Pain generated $167.3M in revenue, accounting 29.68% of the company's total revenue, up 2.95% year-over-year. Digestive Health generated $396.4M in revenue, accounting 70.32% of the company's total revenue, up 6.67% year-over-year.

What is Avanos Medical’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Avanos Medical was Digestive Health. This segment made a revenue of $396.4M, representing 70.32% of the company's total revenue.